{{Rsnum
|rsid=2239785
|Gene=APOL1
|Chromosome=22
|position=36265284
|Orientation=plus
|GMAF=0.2957
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=APOL1
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 61.9 | 31.9 | 6.2
| HCB | 70.1 | 27.0 | 2.9
| JPT | 66.4 | 31.0 | 2.7
| YRI | 4.8 | 44.5 | 50.7
| ASW | 22.8 | 49.1 | 28.1
| CHB | 70.1 | 27.0 | 2.9
| CHD | 67.0 | 30.3 | 2.8
| GIH | 75.2 | 21.8 | 3.0
| LWK | 17.3 | 53.6 | 29.1
| MEX | 77.6 | 20.7 | 1.7
| MKK | 24.4 | 48.1 | 27.6
| TSI | 52.9 | 41.2 | 5.9
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=20668430
|Trait=None
|Title=A risk allele for focal segmental glomerulosclerosis in African Americans is located within a region containing APOL1 and MYH9
|RiskAllele=G
|Pval=5E-13
|OR=None
|ORtxt=None
|OA=1
}}

{{PMID Auto
|PMID=22119407
|Title=Genetic association and gene-gene interaction analyses in African American dialysis patients with nondiabetic nephropathy.
|OA=1
}}

{{GET Evidence
|gene=APOL1
|aa_change=Glu166Lys
|aa_change_short=E166K
|impact=not reviewed
|qualified_impact=Insufficiently evaluated not reviewed
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs2239785
|n_genomes=1
|n_genomes_annotated=0
|n_haplomes=2
|n_articles=0
|n_articles_annotated=0
|nblosum100=0
|autoscore=1
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | Illumina Human 1M}}